Advertisement

Index by author

August 01, 1997; Volume 282,Issue 2

  1. Abebe, Worku

    1. Effect of Low Density Lipoprotein on Adenosine Receptor-Mediated Coronary Vasorelaxation in Vitro
      Worku Abebe and S. Jamal Mustafa
      Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 851-857;

  2. Abercrombie, Elizabeth D.

    1. Striatal Acetylcholine Release Correlates with Behavioral Sensitization in Rats Withdrawn from Chronic Amphetamine
      Michael J. Bickerdike and Elizabeth D. Abercrombie
      Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 818-826;

  3. Ackerman, Bruce H.

    1. Disposition of Vessel Dilator and Long-Acting Natriuretic Peptide in Healthy Humans after a One-Hour Infusion
      Bruce H. Ackerman, Rose M. Overton, Michael T. McCormick, Douglas D. Schocken and David L. Vesely
      Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 603-608;

  4. Adler, Martin W.

    1. Substance P Release in the Rat Periaqueductal Gray and Preoptic Anterior Hypothalamus after Noxious Cold Stimulation: Effect of Selective Mu and Kappa Opioid Agonists
      Li Xin, Ellen B. Geller, Lee-Yuan Liu-Chen, Chongguang Chen and Martin W. Adler
      Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 1055-1063;

  5. Angst, Christian P.

    1. Influence of Oral S-Adenosylmethionine on Plasma 5-Methyltetrahydrofolate, S-Adenosylhomocysteine, Homocysteine and Methionine in Healthy Humans
      Franziska M. T. Loehrer, Roger Schwab, Christian P. Angst, Walter E. Haefeli and Brian Fowler
      Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 845-850;

  6. Anner, Beatrice M.

    1. Endogenous Natriuretic Factors 7: Biospecificity of a Natriuretic γ-Tocopherol Metabolite LLU-α
      E. David Murray, William J. Wechter, Darko Kantoci, Wen-Hui Wang, Tim Pham, David D. Quiggle, Karina M. Gibson, Douglas Leipold and Beatrice M. Anner
      Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 657-662;

  7. Ansell, J.

    1. Evaluation of the Antiinflammatory Activity of a Dual Cyclooxygenase-2 Selective/5-Lipoxygenase Inhibitor, RWJ 63556, in a Canine Model of Inflammation
      T. Kirchner, D. C. Argentieri, A. G. Barbone, M. Singer, M. Steber, J. Ansell, S. A. Beers, M. P. Wachter, W. Wu, E. Malloy, A. Stewart and D. M. Ritchie
      Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 1094-1101;

  8. Argentieri, D. C.

    1. Evaluation of the Antiinflammatory Activity of a Dual Cyclooxygenase-2 Selective/5-Lipoxygenase Inhibitor, RWJ 63556, in a Canine Model of Inflammation
      T. Kirchner, D. C. Argentieri, A. G. Barbone, M. Singer, M. Steber, J. Ansell, S. A. Beers, M. P. Wachter, W. Wu, E. Malloy, A. Stewart and D. M. Ritchie
      Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 1094-1101;

  9. Asano, Satoshi

    1. Potency of Truncated Secretory Leukoprotease Inhibitor Assessed in Acute Lung Injury Models in Hamsters
      Hiroaki Mitsuhashi, Satoshi Asano, Takashi Nonaka, Ken-Ichi Masuda and Mamoru Kiyoki
      Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 1005-1010;

  10. Assie, Marie-Bernadette

    1. Pharmacological Characterization of In Vivo Properties of Putative Mixed 5-HT1AAgonist/5-HT2A/2C Antagonist Anxiolytics. II. Drug Discrimination and Behavioral Observation Studies in Rats
      Mark S. Kleven, Marie-Bernadette Assié and Wouter Koek
      Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 747-759;
« Previous (Pages : 1 2 3 4 5 6 ... 34) Next »
Back to top

In this issue

Advertisement